Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7713973 Kinase inhibitors

Patent 7713973 was granted and assigned to Takeda Pharmaceutical Company on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Takeda Pharmaceutical Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77139730

Patent Inventor Names

Bheema R. Paraselli0

Nicholas Scorah0

Qing Dong0

Zhiyuan Zhang0

David J. Hosfield0

Jeffrey A. Stafford0

Michael B. Wallace0

Date of Patent

May 11, 2010

Patent Application Number

112516160

Date Filed

October 14, 2005

Patent Citations Received

‌

US Patent 11925631 Substituted 6-azabenzimidazole compounds

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7713973 Kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API